Resignation of Director and Officer - Hawaii News Now - KGMB and KHNL

Resignation of Director and Officer

Posted: Updated:

Richmond, VA / ACCESSWIRE / May 16, 2014 / avVaa World Health Care Products Inc. (“the Company”) (Pink Sheets: AVVH) wishes to announce the resignation of Jason Price, CEO as of May 15 2014.

Dr. Mario Zamora the current Director will continue to act in the best interests of the company including providing assistance to appoint a new CEO for the company and continue working with regulatory authorities. Dr. Mario Zamora has been involved with the Company’s product development over the last several years, “I truly believe in the product lines that have been created “says Dr, Mario Zamora”. I anticipate assembling a new Management and Marketing team in the near future so that avVaa will be positioned to aggressively pursue sales and distribution opportunities in North America, and become the diversified natural health products company it set out to be.

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa’s patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin® line of skin care products through mass food and drug channels in the United States and globally. The Company’s secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: http://www.avvaa.com/.

avVaa World Health Care Products
P: 1-866-864-6598
7400 Beaufont Springs Dr, Suite 300
Richmond, VA 23225, United States

Pink Sheets: AVVH

Safe Harbor

This news release contains statements which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of avVaa World Health Care Products, and members of its management, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

Source: avVaa World Health Care Products

ReleaseID: 415711